The global intraocular lens market is projected to grow from its current valuation of $4.1 billion to $6.7 billion by the end of 2032, according to a recent report by Fact Market Research (FMR).

Corcoran Consulting Group (CCG) and Conclusn have teamed up to create a software application that provides proprietary utilization benchmarks for ophthalmic procedures.

Contract research organization TFS HealthScience announced it has acquired Appletree CI Group, a CRO and global regulatory affairs service provider. The terms of the deal were not disclosed.

Topcon Healthcare has received ISO 27001 certification of its Harmony RS Clinical Data Management System. ISO 27001 is a globally recognized standard for the establishment and certification of an information security management system (ISMS).

STADA Arzneimittel AG and Xbrane Biopharma AB announced that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ximluci® (ranibizumab), a biosimilar of Lucentis®. STADA plans to launch Ximluci in the United Kingdom in 2023.

Glaukos announced positive results for a prospective, multicenter clinical trial designed to assess the safety of the surgical exchange procedure for iDose TR (travoprost intraocular implant) in subjects who had previously received an iDose TR.

Rayner has announced the release of "Peer2Peer: The Podcast," the latest edition of their Peer2Peer clinical education platform.

According to Market Scope’s recent report, the global refractive surgery market will generate $12 billion in total retail revenue in 2027, up from $8.9 billion in 2022, representing a 6.2% compound growth rate.

Keranova announced the completion of regulatory clinical tests for its robotic laser technology, FemtoMatrix. Following the positive results, the company said that it will file for CE marking for this new class of surgical equipment in cataract surgery.

Italy-based Sifi formed a collaboration with Avanzanite Bioscience, a Dutch specialty pharmaceutical business, to commercialize and distribute Akantior (polihexanide) exclusively in 26 European Economic Area and Swiss countries.